Male gynecomastia.
Haynes
Bridgett A
BA
Department of Internal Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Mookadam
Farouk
F
D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006177:Gynecomastia / Q000139:chemically induced* / Q000175:diagnosis; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use; D028761:Withholding Treatment
D013148:Spironolactone